The Reproductive Care of Women Living With Hepatitis C Infection
II. Introduction
Hepatitis C virus (HCV), which was first discovered in 1989, is
an important cause of chronic liver disease and is increasingly
recognized as a major public health problem worldwide. It is a bloodborne
pathogen and is the most frequent etiology necessitating liver transplantation,
producing considerable costs to health care systems. It has been
estimated that three percent of the world population is currently
infected with HCV.1 The estimated prevalence in Canada
is 0.8 percent, suggesting a total number of 240,000 infected persons
(Table I).2Only about 30 percent of those infected with
HCV are thought to be aware of their infection. Extrapolation from
the general population data in Canada would suggest that up to one
in 120 deliveries might occur in an infected woman. The incidence
is rising most rapidly in the 20 to 45 year age group, implying
that HCV will be seen more and more commonly in women of childbearing
years.
HCV is responsible for considerable morbidity and mortality, with
the majority of acute infections becoming chronic.3 It
represents the most common cause of chronic viral and posttransfusion
hepatitis, although in Canada the risk of this has fallen to almost
nil since 1990 with the introduction of screening, and ranks only
slightly below chronic alcohol use as a cause of cirrhosis, end-stage
liver disease, and hepatocellular carcinoma.3 Vertical transmission
occurs with variable frequency dependent on the existence of co-factors
and other medical conditions.4,5,6,7 Nosocomial infection
has been reported in both patients and health care workers. HCV
has a huge impact on the family unit in psychological and social
terms, but will also raise specific issues for women regarding contraceptive
choices, pregnancy, assisted reproduction, and hormone replacement
therapy.
The issues for those providing health care to women of childbearing
age are several: identification of at-risk patients
Figure 1 : Prevalence of HCV in Different
Parts of the World
Source: CCDR 2000;26(5).March 2000. *Based on
published data. - Provenant d'Ètudes publishÈes.
and provision of appropriate screening; evidence based counselling
regarding the complex issues related to pregnancy, including vertical
transmission and therapy; patient education; and psychological support
of the identified patient and her family prior to, during, and after
the pregnancy.
The following guideline has been developed to inform,
educate, and prepare the health care community to identify and counsel
women living with HCV.
Back
|